Sherbrooke Park Advisers LLC Regenxbio Inc. Transaction History
Sherbrooke Park Advisers LLC
- $230 Billion
- Q2 2025
A detailed history of Sherbrooke Park Advisers LLC transactions in Regenxbio Inc. stock. As of the latest transaction made, Sherbrooke Park Advisers LLC holds 28,639 shares of RGNX stock, worth $367,151. This represents 0.1% of its overall portfolio holdings.
Number of Shares
28,639
Previous 24,405
17.35%
Holding current value
$367,151
Previous $174 Million
34.75%
% of portfolio
0.1%
Previous 0.08%
Shares
5 transactions
Others Institutions Holding RGNX
# of Institutions
183Shares Held
45.3MCall Options Held
103KPut Options Held
100K-
Black Rock Inc. New York, NY8.61MShares$110 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA4.78MShares$61.2 Million4.77% of portfolio
-
Jpmorgan Chase & CO New York, NY4.36MShares$56 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.42MShares$43.9 Million0.0% of portfolio
-
State Street Corp Boston, MA1.84MShares$23.6 Million0.0% of portfolio
About REGENXBIO Inc.
- Ticker RGNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,230,000
- Market Cap $554M
- Description
- REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...